Robert G. Perry

1.0k citations
12 papers · 645 · 2 hit papers · h-index 8

Impact in

Papers in

Robert G. Perry

10 papers receiving 631 citations

Robert G. Perry's Hit Papers

TVB-2640 (FASN Inhibitor) for the Treatment of Nonalcoholic Steatohepatitis: FASCINATE-1, a Randomized, Placebo-Controlled Phase 2a Trial 2021 · 169 citations
1690+1+3Years since publication50100150200

Peers

Robert G. Perry
Comparison fields: 5 of 84
  • Physiology 247
  • Endocrinology, Diabetes and Metabolism 134
  • Hepatology 45
  • Cell Biology 93
  • Pharmacology 76
Replace Darren M. Gordon with:
Darren M. Gordon United States
Halil Genç Türkiye
Martín Alcalá Spain
Birgitte Nellemann Denmark
Liangming Liu China
Jung A Kim South Korea
Dalong Zhu China
Nasui Wang China
LI De-shan China
Lina Zhao China
Robert G. Perry relative to Darren M. Gordon United States Darren M. Gordon's profile →
Citations per field
00.5×5×10×15×20×24×
Darren M. Gordon · 1×
Citations per year

Countries citing papers authored by Robert G. Perry

Since Specialization
Citations

This map shows the geographic impact of Robert G. Perry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert G. Perry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert G. Perry more than expected).

Fields of papers citing papers by Robert G. Perry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert G. Perry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert G. Perry. The network helps show where Robert G. Perry may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert G. Perry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert G. Perry Line = papers co-authored together Robert G. Perry links everyone, so they are left out of the graph.

All Works

12 of 12 papers shown
#Work
1
Effect of Bimagrumab vs Placebo on Body Fat Mass Among Adults With Type 2 Diabetes and Obesity
Hit paper breakdown →
2021210
2 2017176
3
TVB-2640 (FASN Inhibitor) for the Treatment of Nonalcoholic Steatohepatitis: FASCINATE-1, a Randomized, Placebo-Controlled Phase 2a Trial
Hit paper breakdown →
2021169
4 201728
5 200620
6 201513
7 20189
8 20149
9 20157
10 20203
11
Evaluation Of In Situ Chemical Oxidation Of Soils At A Mixed Waste Site And Assessment Of Effects On Ground Water Quality.
20101
12 19970

About Robert G. Perry

Robert G. Perry is a scholar working on Hepatology, Epidemiology, Water Science and Technology, Infectious Diseases and Pollution, having authored 12 papers that have together received 645 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (2 papers), Hepatitis C virus research (2 papers), Pesticide and Herbicide Environmental Studies (1 paper), Groundwater flow and contamination studies (1 paper), Biosimilars and Bioanalytical Methods (1 paper), Cancer, Lipids, and Metabolism (1 paper), Hydrological Forecasting Using AI (1 paper) and Hydrology and Watershed Management Studies (1 paper). The work is most often cited by research in Physiology (247 citations), Endocrinology, Diabetes and Metabolism (134 citations), Hepatology (45 citations), Cell Biology (93 citations) and Pharmacology (76 citations). Robert G. Perry has collaborated with scholars based in United States, Switzerland and Hong Kong. Frequent co-authors include Ronenn Roubenoff, Daniel Rooks, Didier Laurent, Jens Præstgaard, Olivier Pétricoul, Estelle Lach‐Trifilieff, Sam Hariry, Bret H. Goodpaster, Ram R. Miller and Thomas J. Wade. Their work appears in journals such as Journal of Hepatology, Gastroenterology, Clinical Therapeutics, JAMA Network Open and Hydrogeology Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact